Kidney Cancer Canada makes every attempt to track access to medications and therapies for kidney cancer in each province. The information found this section helps you navigate treatments available in your Province/Territory along with treatment guidelines.
Lists all drugs approved by Health Canada for the treatment of kidney cancer. Please note that access to these treatments differs according to your province therefore you should be sure to read the section on Treatment Access Information by Province/Territory.
Gives information about which drugs can you can access through the public programs in each province or territory. If you have private drug insurance, you may have additional options.
Canadian experts in kidney cancer have developed guidelines for the treatment of localized and advanced kidney cancer, and for screening of potentially hereditary kidney cancer.
Some patients may require additional drugs to treat specific types of metastases such as bone metastases related to renal cell carcinoma. Although some of these drugs are not specifically approved by Health Canada for metastatic renal cell carcinoma (mRCC) physicians may be able to prescribe these drugs because they have been approved by Health Canada for use with other types of cancer(s).
As not all drugs are not currently available under the public formularies for mRCC, patients will need to investigate whether or not these drugs may be covered through their private insurance, by a special access program in their province, or through a clinical trial. Remember to speak first with your oncologist who will best know whether this treatment could be helpful to you.